The most characteristic finding of psoriasis is well-demarcated, raised, erythematous plaques covered with silvery-white scales. This description directly reflects the underlying pathophysiology of the disease. Psoriasis is a chronic, immune-mediated systemic inflammatory condition, where the central pathogenic mechanism involves the interleukin-23/interleukin-17 (IL-23/IL-17) axis [3]. In this process, activated T helper 17 (Th17) cells and group 3 innate lymphoid cells (ILC3s) release pro-inflammatory cytokines, primarily IL-17A, IL-17F, and IL-22 [3].
These cytokines act on keratinocytes, triggering a cascade that results in epidermal hyperproliferation and the sustained inflammatory microenvironment typical of psoriatic lesions [3]. The rapid turnover of skin cells leads to the accumulation of immature keratinocytes on the surface, which clinically manifests as the thick, silvery-white scales. The underlying inflammation causes the dilation of dermal capillaries, producing the raised, erythematous (red) base. The term "well-demarcated" highlights the sharp, distinct border between the affected plaque and the surrounding normal skin, a key feature that helps differentiate it from other dermatological conditions like eczema.
This classic plaque morphology is the hallmark of the most common form of the disease, chronic plaque psoriasis, which affects approximately 1-3% of the global population . The condition is not merely a skin disorder but is perceived as a systemic disease associated with a chronic inflammatory state, often linked to multiple comorbidities .
The other options describe findings characteristic of different dermatological conditions, which is a common testing strategy on the NCLEX-RN.
A thorough integumentary assessment requires the nurse to distinguish between these primary lesion morphologies, as they point to vastly different etiologies, treatment plans, and nursing interventions. In psoriasis, treatment strategies may range from topical anti-inflammatory agents, such as calcipotriol/betamethasone dipropionate combinations, to systemic therapies targeting the IL-23/IL-17 pathway [3].
The most characteristic finding is a well-demarcated, raised, erythematous plaque covered with silvery-white scales. This results from a hyperproliferative epidermis with a rapid turnover rate of 3 to 5 days instead of the normal 28 to 30 days.
Common sites include the extensor surfaces (elbows, knees), scalp, and lower back. The plaques are often symmetrical. Gently scraping a scale may reveal pinpoint bleeding, known as the Auspitz sign.
Do not confuse psoriatic plaques with the honey-colored crusts of impetigo or the irregular borders of actinic keratosis. Always assess for associated psoriatic arthritis, which occurs in up to 30% of patients.
학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.